A.J. Kazimi discloses 38% Cumberland (CPIX) stake in Schedule 13G

Rhea-AI Filing Summary

Cumberland Pharmaceuticals Inc. insider A.J. Kazimi has filed a Schedule 13G reporting a significant ownership position in the company’s common stock. Kazimi beneficially owns 5,701,155 shares of Cumberland common stock, representing 38.07% of the outstanding class.

All of these shares are reported with sole voting and sole dispositive power, meaning Kazimi alone can vote and decide whether to sell or hold them. The filing confirms that no other person is identified as sharing voting or investment control over this ownership stake.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Cumberland Pharmaceuticals Inc.

(Name of Issuer)

Common stock

(Title of Class of Securities)

230770109

(CUSIP Number)

01/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 230770109

1

Names of Reporting Persons

A.J. Kazimi

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 5,789,155.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 5,789,155.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

5,789,155.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

38.4 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Cumberland Pharmaceuticals Inc.
(b)	Address of issuer's principal executive offices: 1600 West End Avenue, Suite 1300, Nashville, TN, 37203
Item 2.
(a)	Name of person filing: A.J. Kazimi
(b)	Address or principal business office or, if none, residence: 1600 West End Avenue, Suite 1300, Nashville, TN 37203
(c)	Citizenship: United States
(d)	Title of class of securities: Common stock
(e)	CUSIP No.: 230770109
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 5701155
(b)	Percent of class: 38.07 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 5701155
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 5701155
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10. Certifications:

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

A.J. Kazimi

Signature:	/s/ A.J. Kazimi
Name/Title:	Chef Executive Officer
Date:	02/09/2026

FAQ

What ownership stake does A.J. Kazimi report in Cumberland Pharmaceuticals (CPIX)?

A.J. Kazimi reports beneficial ownership of 5,701,155 shares of Cumberland Pharmaceuticals common stock, representing 38.07% of the outstanding class. All reported shares carry sole voting and sole dispositive power, indicating exclusive control over how they are voted and potentially sold.

What is the significance of this Schedule 13G filing for Cumberland Pharmaceuticals (CPIX)?

This Schedule 13G shows that A.J. Kazimi holds a sizeable 38.07% beneficial ownership in Cumberland Pharmaceuticals. Such a large stake indicates substantial influence over shareholder votes and corporate decisions, as all reported shares are held with sole voting and dispositive power.

How many Cumberland Pharmaceuticals (CPIX) shares does A.J. Kazimi control?

A.J. Kazimi beneficially owns and controls 5,701,155 shares of Cumberland Pharmaceuticals common stock. The filing states he has sole power to vote and dispose of all these shares, with no shared voting or investment authority indicated for this position.

What percentage of Cumberland Pharmaceuticals’ common stock is owned by A.J. Kazimi?

According to the Schedule 13G, A.J. Kazimi’s beneficial ownership represents 38.07% of Cumberland Pharmaceuticals’ common stock. This percentage reflects his reported 5,701,155 shares relative to the total outstanding shares of the class described in the filing.

Does anyone else share voting or dispositive power over A.J. Kazimi’s CPIX shares?

The filing reports sole voting power and sole dispositive power for all 5,701,155 shares held by A.J. Kazimi. It lists zero shared voting power and zero shared dispositive power, indicating no other party is identified as sharing control over these shares.

What class of securities does this Schedule 13G for Cumberland Pharmaceuticals (CPIX) cover?

The Schedule 13G covers Cumberland Pharmaceuticals’ common stock, identified with CUSIP number 230770109. The filing details A.J. Kazimi’s beneficial ownership and control over this specific class of securities, including voting and dispositive powers for the reported share position.